Quantifying CDK inhibitor selectivity in live cells

Cyclin-dependent kinase (CDK) inhibitors are widely used both in the clinic and for basic research aimed at dissecting the specific cellular functions of specific CDKs. Here, the authors report the development of a panel of fluorescent reporter probes and provide a comprehensive profile of the inhib...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Carrow I. Wells, James D. Vasta, Cesear R. Corona, Jennifer Wilkinson, Chad A. Zimprich, Morgan R. Ingold, Julie E. Pickett, David H. Drewry, Kathryn M. Pugh, Marie K. Schwinn, Byounghoon (Brian) Hwang, Hicham Zegzouti, Kilian V. M. Huber, Mei Cong, Poncho L. Meisenheimer, Timothy M. Willson, Matthew B. Robers
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2020
Materias:	Science Q
Acceso en línea:	https://doaj.org/article/5ab2cf72cb7f4b5ea0a65e02f4e02daf
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5ab2cf72cb7f4b5ea0a65e02f4e02daf
record_format	dspace
spelling	oai:doaj.org-article:5ab2cf72cb7f4b5ea0a65e02f4e02daf2021-12-02T18:24:49ZQuantifying CDK inhibitor selectivity in live cells10.1038/s41467-020-16559-02041-1723https://doaj.org/article/5ab2cf72cb7f4b5ea0a65e02f4e02daf2020-06-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-16559-0https://doaj.org/toc/2041-1723Cyclin-dependent kinase (CDK) inhibitors are widely used both in the clinic and for basic research aimed at dissecting the specific cellular functions of specific CDKs. Here, the authors report the development of a panel of fluorescent reporter probes and provide a comprehensive profile of the inhibitory activity of several CDK inhibitors towards all 21 CDKs in living cells.Carrow I. WellsJames D. VastaCesear R. CoronaJennifer WilkinsonChad A. ZimprichMorgan R. IngoldJulie E. PickettDavid H. DrewryKathryn M. PughMarie K. SchwinnByounghoon (Brian) HwangHicham ZegzoutiKilian V. M. HuberMei CongPoncho L. MeisenheimerTimothy M. WillsonMatthew B. RobersNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-11 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	Science Q
spellingShingle	Science Q Carrow I. Wells James D. Vasta Cesear R. Corona Jennifer Wilkinson Chad A. Zimprich Morgan R. Ingold Julie E. Pickett David H. Drewry Kathryn M. Pugh Marie K. Schwinn Byounghoon (Brian) Hwang Hicham Zegzouti Kilian V. M. Huber Mei Cong Poncho L. Meisenheimer Timothy M. Willson Matthew B. Robers Quantifying CDK inhibitor selectivity in live cells
description	Cyclin-dependent kinase (CDK) inhibitors are widely used both in the clinic and for basic research aimed at dissecting the specific cellular functions of specific CDKs. Here, the authors report the development of a panel of fluorescent reporter probes and provide a comprehensive profile of the inhibitory activity of several CDK inhibitors towards all 21 CDKs in living cells.
format	article
author	Carrow I. Wells James D. Vasta Cesear R. Corona Jennifer Wilkinson Chad A. Zimprich Morgan R. Ingold Julie E. Pickett David H. Drewry Kathryn M. Pugh Marie K. Schwinn Byounghoon (Brian) Hwang Hicham Zegzouti Kilian V. M. Huber Mei Cong Poncho L. Meisenheimer Timothy M. Willson Matthew B. Robers
author_facet	Carrow I. Wells James D. Vasta Cesear R. Corona Jennifer Wilkinson Chad A. Zimprich Morgan R. Ingold Julie E. Pickett David H. Drewry Kathryn M. Pugh Marie K. Schwinn Byounghoon (Brian) Hwang Hicham Zegzouti Kilian V. M. Huber Mei Cong Poncho L. Meisenheimer Timothy M. Willson Matthew B. Robers
author_sort	Carrow I. Wells
title	Quantifying CDK inhibitor selectivity in live cells
title_short	Quantifying CDK inhibitor selectivity in live cells
title_full	Quantifying CDK inhibitor selectivity in live cells
title_fullStr	Quantifying CDK inhibitor selectivity in live cells
title_full_unstemmed	Quantifying CDK inhibitor selectivity in live cells
title_sort	quantifying cdk inhibitor selectivity in live cells
publisher	Nature Portfolio
publishDate	2020
url	https://doaj.org/article/5ab2cf72cb7f4b5ea0a65e02f4e02daf
work_keys_str_mv	AT carrowiwells quantifyingcdkinhibitorselectivityinlivecells AT jamesdvasta quantifyingcdkinhibitorselectivityinlivecells AT cesearrcorona quantifyingcdkinhibitorselectivityinlivecells AT jenniferwilkinson quantifyingcdkinhibitorselectivityinlivecells AT chadazimprich quantifyingcdkinhibitorselectivityinlivecells AT morganringold quantifyingcdkinhibitorselectivityinlivecells AT julieepickett quantifyingcdkinhibitorselectivityinlivecells AT davidhdrewry quantifyingcdkinhibitorselectivityinlivecells AT kathrynmpugh quantifyingcdkinhibitorselectivityinlivecells AT mariekschwinn quantifyingcdkinhibitorselectivityinlivecells AT byounghoonbrianhwang quantifyingcdkinhibitorselectivityinlivecells AT hichamzegzouti quantifyingcdkinhibitorselectivityinlivecells AT kilianvmhuber quantifyingcdkinhibitorselectivityinlivecells AT meicong quantifyingcdkinhibitorselectivityinlivecells AT poncholmeisenheimer quantifyingcdkinhibitorselectivityinlivecells AT timothymwillson quantifyingcdkinhibitorselectivityinlivecells AT matthewbrobers quantifyingcdkinhibitorselectivityinlivecells
_version_	1718378096566992896

Quantifying CDK inhibitor selectivity in live cells

Ejemplares similares